Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery

ClinicalTrials.gov ID: NCT00575380

Public ClinicalTrials.gov record NCT00575380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 2:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label, Randomized Study of the Pharmacokinetics of Azithromycin Versus Moxifloxacin in Conjunctiva and Aqueous Humor Following Single or Multiple Ocular Administration of AzaSite Ophthalmic Solution, 1% or Vigamox in Subjects Undergoing Routine Cataract Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the drug concentrations in the conjunctiva and aqueous humor of AzaSite™ compared to Vigamox® in subjects undergoing routine cataract surgery

Study identification

NCT ID
NCT00575380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
116 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
May 31, 2008
Completion
Not listed
Last update posted
Sep 21, 2011

Started 2007

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Cornea Consultants of Arizone Phoenix Arizona 85032
Eye Care Arkansas Little Rock Arkansas 72205
North Valley Eye Medical Group Mission Hills California 91345
Center for Excellence in Eye Care Miami Florida 33176
Eye Center of North Florida Panama City Florida 32405
Coastal Research Associates, LLC Atlanta Georgia 30339
Kentuckiana Institute for Eye Research Louisville Kentucky 40207
Ophthalmology Associates St Louis Missouri 63131
Ophthalmic Consultants of Long Island Rockville Centre New York 11563
Eye Care Specialists Kingston Pennsylvania 18704
Medical University of South Carolina Charleston South Carolina 29464
Glaucoma Consultants and Center for Eye Research Mt. Pleasant South Carolina 29464
Corona Research Consultants El Paso Texas 79904

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00575380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2011 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00575380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →